Free Trial

BILL (BILL) Financials

BILL logo
$37.07 -1.25 (-3.27%)
Closing price 03:59 PM Eastern
Extended Trading
$37.00 -0.07 (-0.18%)
As of 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for BILL

Annual Income Statements for BILL

This table shows BILL's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-7.20 -7.31 -31 -99 -326 -224 -29 24
Consolidated Net Income / (Loss)
-7.20 -7.31 -31 -99 -326 -224 -29 24
Net Income / (Loss) Continuing Operations
-7.20 -7.31 -31 -99 -326 -224 -29 24
Total Pre-Tax Income
-7.19 -7.47 -31 -139 -331 -223 -26 30
Total Operating Income
-7.82 -9.80 -34 -114 -317 -296 -174 -81
Total Gross Profit
45 78 118 176 497 864 1,056 1,190
Total Revenue
65 108 158 238 642 1,058 1,290 1,463
Operating Revenue
65 108 158 238 642 1,058 1,290 1,463
Total Cost of Revenue
19 30 39 62 145 194 235 272
Operating Cost of Revenue
19 30 39 62 145 194 235 272
Total Operating Expenses
53 88 153 290 814 1,160 1,230 1,271
Selling, General & Admin Expense
16 29 53 128 221 249 278 282
Marketing Expense
19 30 45 68 307 516 479 544
Research & Development Expense
18 29 53 90 220 315 337 340
Depreciation Expense
- - 1.14 4.87 46 48 49 33
Other Operating Expenses / (Income)
- - - - 20 32 60 73
Restructuring Charge
- - - - 0.00 0.00 28 0.00
Total Other Income / (Expense), net
0.63 2.33 3.16 -25 -14 73 148 111
Other Income / (Expense), net
0.63 2.33 3.16 -25 -14 73 148 111
Income Tax Expense
0.01 -0.16 0.05 -41 -4.32 0.81 2.56 6.61
Basic Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) ($3.21) ($2.11) ($0.27) $0.23
Weighted Average Basic Shares Outstanding
7.16M 7.80M 44.11M 82.81M 101.75M 105.98M 106.10M 103.57M
Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) ($3.21) ($2.11) ($0.27) ($0.07)
Weighted Average Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 101.75M 105.98M 106.10M 103.91M
Weighted Average Basic & Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 104.84M 106.61M 106.69M 101.63M

Quarterly Income Statements for BILL

This table shows BILL's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-31 -16 -28 -40 32 7.60 8.91 34 -12 -2.96 -2.59
Consolidated Net Income / (Loss)
-31 -16 -28 -40 32 7.60 8.91 34 -12 -2.96 -2.59
Net Income / (Loss) Continuing Operations
-31 -16 -28 -40 32 7.60 8.91 34 -12 -2.96 -2.59
Total Pre-Tax Income
-31 -15 -27 -39 32 7.60 10 34 -10 -2.81 -2.07
Total Operating Income
-54 -41 -57 -68 -28 -22 -7.70 -22 -29 -21 -18
Total Gross Profit
224 243 249 260 268 278 294 296 291 319 331
Total Revenue
273 296 305 318 323 344 358 363 358 396 415
Operating Revenue
273 296 305 318 323 344 358 363 358 396 415
Total Cost of Revenue
49 53 56 58 55 65 65 67 67 77 84
Operating Cost of Revenue
49 53 56 58 55 65 65 67 67 77 84
Total Operating Expenses
278 285 306 328 296 301 301 318 320 339 349
Selling, General & Admin Expense
72 41 73 70 64 25 67 71 74 77 79
Marketing Expense
115 117 118 118 118 124 126 133 137 149 155
Research & Development Expense
79 82 89 86 82 80 79 85 87 80 83
Depreciation Expense
12 12 13 12 12 12 9.01 7.86 7.86 8.07 8.38
Other Operating Expenses / (Income)
- - 12 16 18 - 21 21 15 16 23
Restructuring Charge
0.00 - - 25 2.10 - 0.00 0.00 0.00 8.87 0.41
Total Other Income / (Expense), net
24 26 29 29 60 30 18 55 19 18 16
Other Income / (Expense), net
24 26 29 29 60 30 18 55 19 18 16
Income Tax Expense
0.54 0.74 0.52 1.67 0.37 0.00 1.27 0.05 1.29 0.15 0.52
Basic Earnings per Share
($0.29) ($0.14) ($0.26) ($0.38) $0.30 $0.07 $0.08 $0.33 ($0.11) ($0.03) ($0.03)
Weighted Average Basic Shares Outstanding
106.60M 105.98M 106.82M 105.91M 105.44M 106.10M 105.67M 103.10M 102.22M 101.92M 100.53M
Diluted Earnings per Share
($0.29) ($0.14) ($0.26) ($0.38) $0.00 $0.37 $0.08 ($0.06) ($0.11) ($0.03) ($0.03)
Weighted Average Diluted Shares Outstanding
106.60M 105.98M 106.82M 105.91M 111.18M 106.10M 107.32M 104.48M 102.22M 101.92M 100.53M
Weighted Average Basic & Diluted Shares Outstanding
106.27M 106.61M 103.50M 105.13M 106.14M 106.69M - 101.95M 103.03M 100.16M 98.96M

Annual Cash Flow Statements for BILL

This table details how cash moves in and out of BILL's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents
-100 392 609 217 1,733 682 -873 199
Net Cash From Operating Activities
-8.36 -3.95 -4.43 4.62 -18 188 279 351
Net Cash From Continuing Operating Activities
-8.36 -3.95 -4.43 4.62 -18 188 279 351
Net Income / (Loss) Continuing Operations
-7.20 -7.31 -31 -99 -326 -224 -29 24
Consolidated Net Income / (Loss)
-7.20 -7.31 -31 -99 -326 -224 -29 24
Depreciation Expense
2.31 3.15 3.23 4.44 9.16 11 14 13
Amortization Expense
0.00 -1.32 -2.79 39 95 54 41 44
Non-Cash Adjustments To Reconcile Net Income
1.22 4.21 19 73 225 355 263 262
Changes in Operating Assets and Liabilities, net
-4.70 -2.68 7.44 -13 -20 -8.97 -9.34 7.59
Net Cash From Investing Activities
-418 -96 -249 -1,427 -1,127 259 -409 -817
Net Cash From Continuing Investing Activities
-418 -96 -249 -1,427 -1,127 259 -409 -817
Purchase of Property, Plant & Equipment
-2.05 -4.30 -12 -21 -16 -31 -21 -38
Acquisitions
- 0.00 0.00 -556 -144 -29 0.00 -2.87
Purchase of Investments
-727 -831 -1,089 -2,070 -2,802 -2,750 -3,042 -3,647
Divestitures
- - 0.00 0.00 6.70 2.08 0.00 0.00
Sale and/or Maturity of Investments
307 749 852 1,247 1,958 3,300 2,840 3,002
Other Investing Activities, net
3.69 -10 -0.96 -26 -131 -233 -186 -132
Net Cash From Financing Activities
326 492 863 1,640 2,879 235 -743 667
Net Cash From Continuing Financing Activities
326 492 863 1,640 2,879 235 -743 667
Repayment of Debt
-3.39 -9.50 0.00 -2.30 -40 0.00 -933 -565
Repurchase of Common Equity
- - - 0.00 0.00 -88 -212 -430
Issuance of Debt
9.50 0.00 2.30 1,129 598 60 45 1,400
Issuance of Common Equity
0.00 0.00 534 8.86 1,354 18 16 12
Other Financing Activities, net
264 416 327 504 967 245 341 250
Cash Interest Paid
0.44 0.87 0.17 0.11 4.87 7.44 13 14
Cash Income Taxes Paid
- - - 0.00 0.00 1.27 5.63 6.32

Quarterly Cash Flow Statements for BILL

This table details how cash moves in and out of BILL's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 6/30/2023 9/30/2024 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
655 -156 220 -1,353 16 -156 626 -650 380 -11 129
Net Cash From Operating Activities
80 89 80 67 79 89 79 100 84 97 105
Net Cash From Continuing Operating Activities
80 89 80 72 73 89 79 100 84 97 105
Net Income / (Loss) Continuing Operations
-16 8.91 -40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59
Consolidated Net Income / (Loss)
-16 8.91 -40 32 7.60 8.91 34 -12 -7.07 -2.96 -2.59
Depreciation Expense
3.35 3.17 3.24 3.21 3.67 3.17 3.51 3.17 3.16 3.84 7.62
Amortization Expense
9.69 9.54 13 9.35 7.62 9.54 10 12 13 14 23
Non-Cash Adjustments To Reconcile Net Income
69 73 82 49 53 73 44 74 71 71 82
Changes in Operating Assets and Liabilities, net
15 -5.94 22 -21 1.04 -5.94 -12 22 4.09 11 -4.94
Net Cash From Investing Activities
379 -140 -50 -618 -43 -140 9.84 -644 -44 -109 137
Net Cash From Continuing Investing Activities
379 -140 -50 -618 -43 -140 9.84 -644 -44 -109 137
Purchase of Property, Plant & Equipment
-7.47 -7.04 -5.12 -3.85 -5.53 -7.06 -7.10 -9.01 -15 -15 -14
Purchase of Investments
-355 -820 -668 -1,301 -641 -820 -772 -1,301 -755 -614 -579
Sale and/or Maturity of Investments
777 736 593 675 789 736 737 819 710 573 724
Other Investing Activities, net
-36 -48 30 12 -186 -48 55 -154 16 -53 5.85
Net Cash From Financing Activities
195 -105 191 -801 -20 -105 538 -106 340 1.10 -113
Net Cash From Continuing Financing Activities
195 -105 191 -801 -20 -105 538 -106 340 1.10 -113
Repurchase of Common Equity
-64 -200 -200 - - -200 -200 - -30 -83 -133
Issuance of Common Equity
- 5.30 - 8.65 - 5.30 - - 6.25 0.00 4.65
Other Financing Activities, net
259 90 391 -144 202 90 -100 -105 365 -66 50

Annual Balance Sheets for BILL

This table presents BILL's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets
1,526 2,404 5,969 9,256 9,636 9,179 10,064
Total Current Assets
1,513 2,379 3,606 6,279 6,673 6,315 7,239
Cash & Equivalents
90 574 510 1,597 1,617 986 1,038
Restricted Cash
1,329 1,644 2,209 3,143 3,356 3,705 4,044
Short-Term Investments
72 124 655 1,108 1,043 602 1,180
Accounts Receivable
4.40 4.25 18 24 28 28 32
Prepaid Expenses
12 27 67 151 170 297 258
Other Current Assets
4.80 6.55 147 256 459 697 685
Plant, Property, & Equipment, net
6.56 14 49 57 82 88 117
Total Noncurrent Assets
6.64 11 2,314 2,920 2,881 2,776 2,709
Goodwill
- 0.00 1,772 2,363 2,397 2,397 2,397
Intangible Assets
- 0.00 417 433 361 281 223
Other Noncurrent Operating Assets
6.64 11 125 124 123 98 89
Total Liabilities & Shareholders' Equity
1,526 2,404 5,969 9,256 9,636 9,179 10,064
Total Liabilities
1,353 1,693 3,440 5,212 5,550 5,045 6,150
Total Current Liabilities
1,349 1,677 2,326 3,409 3,753 4,063 4,589
Short-Term Debt
0.00 - 0.00 75 135 0.00 213
Accounts Payable
5.06 3.48 12 9.95 8.52 7.45 16
Accrued Expenses
6.56 11 72 120 195 300 252
Customer Deposits
1,329 1,644 2,209 3,143 3,356 3,705 4,044
Current Deferred Revenue
3.47 5.89 13 32 26 17 22
Current Employee Benefit Liabilities
4.33 12 20 29 33 34 40
Total Noncurrent Liabilities
3.23 16 1,114 1,804 1,797 982 1,561
Long-Term Debt
- 0.00 989 1,698 1,705 914 1,501
Noncurrent Deferred Revenue
1.79 2.62 2.93 2.16 0.41 4.17 0.29
Other Noncurrent Operating Liabilities
1.45 14 122 104 91 63 60
Commitments & Contingencies
0.00 0.00 - - - - 0.00
Total Equity & Noncontrolling Interests
-103 711 2,530 4,044 4,086 4,134 3,914
Total Preferred & Common Equity
-103 711 2,530 4,044 4,086 4,134 3,914
Total Common Equity
-103 711 2,530 4,044 4,086 4,134 3,914
Common Stock
15 857 2,777 4,599 4,947 5,233 5,415
Retained Earnings
-118 -149 -247 -545 -856 -1,097 -1,511
Accumulated Other Comprehensive Income / (Loss)
0.33 2.42 -0.10 -10 -4.49 -1.89 10

Quarterly Balance Sheets for BILL

This table presents BILL's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2022 9/30/2022 12/31/2022 3/31/2023 9/30/2024 12/31/2023 3/31/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025
Total Assets
9,184 9,253 9,738 9,381 9,045 9,872 9,122 9,674 9,633 10,151 10,126
Total Current Assets
6,183 6,292 6,748 6,405 6,204 6,956 6,228 6,840 6,804 7,330 7,325
Cash & Equivalents
1,639 1,609 1,617 1,591 853 1,580 952 1,566 1,048 1,100 1,095
Restricted Cash
3,044 3,122 3,474 3,106 3,787 3,655 3,511 3,767 3,657 3,975 4,032
Short-Term Investments
1,143 1,035 1,067 1,073 620 973 837 645 1,125 1,215 1,147
Accounts Receivable
27 29 31 34 32 27 30 29 27 32 41
Prepaid Expenses
92 140 179 170 284 205 256 252 241 269 278
Other Current Assets
238 358 381 431 628 517 642 582 706 739 732
Plant, Property, & Equipment, net
53 62 69 77 90 87 87 94 105 129 127
Total Noncurrent Assets
2,948 2,899 2,921 2,898 2,751 2,830 2,806 2,740 2,724 2,692 2,674
Goodwill
2,363 2,362 2,397 2,397 2,397 2,397 2,397 2,397 2,397 2,397 2,397
Intangible Assets
452 413 402 382 265 321 301 253 238 208 192
Other Noncurrent Operating Assets
133 124 122 120 89 112 109 90 89 88 85
Total Liabilities & Shareholders' Equity
9,184 9,253 9,738 9,381 9,045 9,872 9,122 9,674 9,633 10,151 10,126
Total Liabilities
5,116 5,206 5,654 5,277 5,032 5,921 5,064 5,865 5,762 6,269 6,320
Total Current Liabilities
4,392 3,326 3,731 3,335 4,056 4,118 3,827 4,122 4,018 4,378 4,430
Short-Term Debt
1,165 0.00 0.00 0.00 - 135 0.00 33 33 33 0.00
Accounts Payable
9.43 12 14 9.14 11 8.77 6.82 5.72 9.30 7.00 5.04
Accrued Expenses
155 142 182 171 212 268 264 266 263 306 339
Customer Deposits
3,044 3,122 3,474 3,106 3,787 3,655 3,511 3,767 3,657 3,975 4,032
Current Deferred Revenue
- 30 30 28 22 17 18 22 22 21 21
Current Employee Benefit Liabilities
18 21 31 21 23 33 28 29 33 36 33
Total Noncurrent Liabilities
724 1,880 1,923 1,941 976 1,802 1,237 1,743 1,745 1,890 1,889
Long-Term Debt
610 1,775 1,814 1,838 915 1,708 1,146 1,678 1,680 1,832 1,834
Noncurrent Deferred Revenue
- 2.32 2.01 1.26 0.10 4.17 4.16 0.20 0.25 0.35 0.42
Other Noncurrent Operating Liabilities
114 102 107 102 61 90 87 64 65 58 55
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,068 4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807
Total Preferred & Common Equity
4,068 4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807
Total Common Equity
4,068 4,048 4,084 4,104 4,013 3,952 4,059 3,809 3,870 3,883 3,807
Common Stock
4,536 4,684 4,812 4,887 5,294 5,089 5,165 5,267 5,332 5,465 5,524
Retained Earnings
-460 -626 -722 -780 -1,290 -1,137 -1,105 -1,458 -1,469 -1,595 -1,731
Accumulated Other Comprehensive Income / (Loss)
-7.50 -10 -6.36 -3.18 9.12 0.24 -1.51 -0.24 7.28 13 14

Annual Metrics And Ratios for BILL

This table displays calculated financial ratios and metrics derived from BILL's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 67.04% 45.45% 51.18% 169.43% 64.88% 21.89% 13.36%
EBITDA Growth
0.00% -15.68% -442.96% -214.11% -136.21% 30.63% 117.79% 212.61%
EBIT Growth
0.00% -3.97% -315.50% -348.92% -137.32% 32.59% 88.19% 215.54%
NOPAT Growth
0.00% -25.41% -248.85% -233.26% -177.99% 6.64% 41.12% 48.26%
Net Income Growth
0.00% -1.65% -325.09% -217.52% -230.59% 31.45% 87.09% 182.41%
EPS Growth
0.00% 6.93% 25.53% -70.00% -169.75% 34.27% 87.20% 74.07%
Operating Cash Flow Growth
0.00% 52.74% -12.18% 204.36% -491.37% 1,137.79% 48.47% 25.78%
Free Cash Flow Firm Growth
0.00% 0.00% -77.94% -741.72% 97.55% -225.01% 121.61% 925.75%
Invested Capital Growth
0.00% 0.00% -23.77% 108.92% -121.26% -192.29% -170.19% -159.81%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 17.89% 23.45% 9.95% 3.84% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -111.44% 0.69% 26.37% 297.79% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -108.94% -0.66% 23.69% 46.34% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -112.99% -4.15% 12.42% 9.92% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -48.77% -15.21% 23.59% 44.83% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% -376.00% -10.69% 24.10% 65.38% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 132.41% -277.96% 93.70% -0.62% 1.50%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 97.87% 62.37% -75.97% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 107.66% -284.81% -152.38% -155.56% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
70.13% 72.39% 75.16% 74.06% 77.41% 81.67% 81.82% 81.40%
EBITDA Margin
-7.51% -5.20% -19.41% -40.34% -35.36% -14.88% 2.17% 5.99%
Operating Margin
-12.05% -9.05% -21.70% -47.83% -49.35% -27.94% -13.50% -5.51%
EBIT Margin
-11.08% -6.89% -19.69% -58.48% -51.51% -21.06% -2.04% 2.08%
Profit (Net Income) Margin
-11.09% -6.75% -19.73% -41.43% -50.84% -21.14% -2.24% 1.63%
Tax Burden Percent
100.14% 97.91% 100.17% 70.85% 98.69% 100.36% 109.72% 78.26%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 21.74%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -387.29% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -384.05% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 377.36% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -4.21% -7.03% -6.09% -9.93% -5.50% -0.70% 0.59%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -1,276.35% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -0.49% -1.58% -3.33% -4.34% -2.36% -0.28% 0.32%
Return on Assets (ROA)
0.00% -0.48% -1.58% -2.36% -4.29% -2.37% -0.31% 0.25%
Return on Common Equity (ROCE)
0.00% 2.49% -4.83% -6.09% -9.93% -5.50% -0.70% 0.59%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.12% -4.37% -3.90% -8.07% -5.48% -0.70% 0.00%
Net Operating Profit after Tax (NOPAT)
-5.47 -6.86 -24 -80 -222 -207 -122 -63
NOPAT Margin
-8.44% -6.33% -15.19% -33.48% -34.55% -19.56% -9.45% -4.31%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.06% -0.37% -0.80% -3.24% -0.40% 2.18% 1.95%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -1.12%
Cost of Revenue to Revenue
29.87% 27.61% 24.84% 25.94% 22.59% 18.33% 18.18% 18.60%
SG&A Expenses to Revenue
24.72% 26.95% 33.92% 53.77% 34.43% 23.53% 21.52% 19.28%
R&D to Revenue
27.73% 26.69% 33.63% 37.56% 34.24% 29.73% 26.10% 23.25%
Operating Expenses to Revenue
82.19% 81.44% 96.86% 121.89% 126.76% 109.62% 95.31% 86.91%
Earnings before Interest and Taxes (EBIT)
-7.19 -7.47 -31 -139 -331 -223 -26 30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.87 -5.64 -31 -96 -227 -157 28 88
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 9.21 6.03 2.83 0.00 1.35 1.22
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.21 44.80 9.18 0.00 3.84 3.68
Price to Revenue (P/Rev)
3.33 1.99 41.54 63.97 17.86 0.00 4.33 3.26
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 200.26
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.50%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 88.40 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 26.68 53.96 11.51 0.00 0.94 0.15
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 43.06 2.48
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.15
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 2,781.04 0.00 0.00 4.33 0.62
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 14.54 0.00 0.00 0.00 37.83 0.67
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.39 0.44 0.45 0.22 0.44
Long-Term Debt to Equity
0.00 0.00 0.00 0.39 0.42 0.42 0.22 0.38
Financial Leverage
0.00 -8.59 -4.33 -1.46 -0.98 -1.01 -1.04 -1.11
Leverage Ratio
0.00 8.79 4.44 2.58 2.32 2.32 2.29 2.39
Compound Leverage Factor
0.00 8.79 4.44 2.58 2.32 2.32 2.29 2.39
Debt to Total Capital
0.00% 0.00% 0.00% 28.12% 30.48% 31.05% 18.11% 30.46%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 1.29% 2.28% 0.00% 3.79%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 28.12% 29.19% 28.77% 18.11% 26.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 159.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -59.12% 100.00% 71.88% 69.52% 68.95% 81.89% 69.54%
Debt to EBITDA
0.00 0.00 0.00 -10.29 -7.81 -11.68 32.62 19.57
Net Debt to EBITDA
0.00 0.00 0.00 24.81 17.95 26.52 -156.26 -51.93
Long-Term Debt to EBITDA
0.00 0.00 0.00 -10.29 -7.48 -10.83 32.62 17.14
Debt to NOPAT
0.00 0.00 0.00 -12.40 -8.00 -8.89 -7.50 -27.18
Net Debt to NOPAT
0.00 0.00 0.00 29.89 18.37 20.17 35.91 72.11
Long-Term Debt to NOPAT
0.00 0.00 0.00 -12.40 -7.66 -8.23 -7.50 -23.80
Altman Z-Score
0.00 0.17 2.61 2.82 1.56 0.00 0.92 0.73
Noncontrolling Interest Sharing Ratio
0.00% 159.12% 31.24% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 1.12 1.42 1.55 1.84 1.78 1.55 1.58
Quick Ratio
0.00 0.12 0.42 0.51 0.80 0.72 0.40 0.49
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 1,311 289 -1,856 -45 -148 32 327
Operating Cash Flow to CapEx
-408.41% -91.86% -36.68% 21.80% -115.71% 601.76% 1,334.28% 920.28%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.07 0.08 0.06 0.08 0.11 0.14 0.15
Accounts Receivable Turnover
0.00 24.64 36.44 21.20 30.38 40.49 45.85 48.44
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 16.52 15.43 7.59 12.13 15.28 15.21 14.29
Accounts Payable Turnover
0.00 5.91 9.17 8.04 13.27 21.01 29.39 22.92
Days Sales Outstanding (DSO)
0.00 14.82 10.02 17.21 12.02 9.01 7.96 7.54
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 61.77 39.82 45.42 27.50 17.37 12.42 15.92
Cash Conversion Cycle (CCC)
0.00 -46.95 -29.80 -28.21 -15.49 -8.36 -4.46 -8.39
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 -1,318 -1,631 145 -31 -90 -244 -634
Invested Capital Turnover
0.00 -0.16 -0.11 -0.32 11.21 -17.45 -7.71 -3.33
Increase / (Decrease) in Invested Capital
0.00 -1,318 -313 1,777 -176 -59 -154 -390
Enterprise Value (EV)
0.00 -999 4,205 12,857 7,389 0.00 1,207 218
Market Capitalization
216 216 6,547 15,241 11,463 0.00 5,585 4,766
Book Value per Share
$0.00 ($13.17) $9.79 $30.40 $38.78 $38.56 $38.95 $37.99
Tangible Book Value per Share
$0.00 ($13.17) $9.79 $4.09 $11.97 $12.53 $13.72 $12.57
Total Capital
0.00 174 711 3,519 5,817 5,926 5,048 5,629
Total Debt
0.00 0.00 0.00 989 1,773 1,840 914 1,714
Total Long-Term Debt
0.00 0.00 0.00 989 1,698 1,705 914 1,501
Net Debt
0.00 -1,492 -2,342 -2,384 -4,075 -4,176 -4,378 -4,548
Capital Expenditures (CapEx)
2.05 4.30 12 21 16 31 21 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -1,328 -1,639 -2,093 -2,902 -2,961 -3,041 -3,399
Debt-free Net Working Capital (DFNWC)
0.00 164 703 1,280 2,946 3,055 2,252 2,864
Net Working Capital (NWC)
0.00 164 703 1,280 2,871 2,920 2,252 2,650
Net Nonoperating Expense (NNE)
1.72 0.45 7.15 19 105 17 -93 -87
Net Nonoperating Obligations (NNO)
0.00 -1,492 -2,342 -2,384 -4,075 -4,176 -4,378 -4,548
Total Depreciation and Amortization (D&A)
2.31 1.84 0.44 43 104 65 54 57
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -1,225.55% -1,040.14% -878.50% -452.03% -279.78% -235.67% -232.42%
Debt-free Net Working Capital to Revenue
0.00% 151.07% 445.81% 537.38% 458.88% 288.60% 174.53% 195.79%
Net Working Capital to Revenue
0.00% 151.07% 445.81% 537.38% 447.18% 275.84% 174.53% 181.20%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 ($2.11) ($0.27) $0.23
Adjusted Weighted Average Basic Shares Outstanding
7.16M 7.80M 80.18M 94.78M 0.00 105.98M 106.10M 103.57M
Adjusted Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 ($2.11) ($0.27) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding
7.16M 7.80M 80.18M 94.78M 0.00 105.98M 106.10M 103.91M
Adjusted Basic & Diluted Earnings per Share
($1.01) ($0.94) ($0.70) ($1.19) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.16M 7.80M 44.11M 82.81M 0.00 106.61M 106.69M 101.63M
Normalized Net Operating Profit after Tax (NOPAT)
-5.47 -6.86 -24 -80 -222 -207 -103 -63
Normalized NOPAT Margin
-8.44% -6.33% -15.19% -33.48% -34.55% -19.56% -7.95% -4.31%
Pre Tax Income Margin
-11.08% -6.89% -19.69% -58.48% -51.51% -21.06% -2.04% 2.08%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -39.16% -733.78% 1,806.81%

Quarterly Metrics And Ratios for BILL

This table displays calculated financial ratios and metrics derived from BILL's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
63.29% 47.83% 32.65% 22.50% 18.52% 16.11% 17.53% 13.83% 10.89% 10.40% 14.38%
EBITDA Growth
69.89% 96.42% 75.20% 71.64% 348.32% 1,002.68% -5.19% 286.53% -89.27% -35.14% -39.59%
EBIT Growth
65.07% 82.05% 66.56% 59.39% 205.17% 150.19% 0.00% 186.68% -132.00% -127.63% -106.15%
NOPAT Growth
34.82% 50.34% 35.40% 39.83% 28.06% 23.33% 0.00% 54.23% 25.79% -115.21% 41.64%
Net Income Growth
64.09% 81.32% 65.87% 57.49% 202.15% 147.85% 131.99% 183.00% -136.43% -133.24% -107.71%
EPS Growth
65.48% 82.72% 66.67% 57.78% 100.00% 364.29% 130.77% 84.21% 0.00% -137.50% 50.00%
Operating Cash Flow Growth
28.69% 867.19% 388.00% 44.27% 96.32% -2.16% 0.00% 0.00% 48.98% 9.34% 33.79%
Free Cash Flow Firm Growth
90.18% -74.18% -29.37% 186.46% 224.27% 331.79% -188.59% -79.27% -45.66% 255.40% 649.99%
Invested Capital Growth
931.35% -192.29% -681.26% -59.00% -155.37% -170.19% 0.00% -10.57% -158.16% 0.00% -38.82%
Revenue Q/Q Growth
4.83% 8.60% 3.04% 4.43% 1.42% 6.39% 4.30% 0.00% -1.20% 0.00% 4.78%
EBITDA Q/Q Growth
77.01% 88.39% -599.52% -51.85% 301.32% -57.79% 21.19% 0.00% -88.42% 0.00% 92.18%
EBIT Q/Q Growth
67.94% 50.54% -80.66% -41.76% 183.03% -76.39% 34.02% 0.00% -130.65% 0.00% 26.56%
NOPAT Q/Q Growth
51.79% 23.65% -36.84% -19.47% 42.36% 18.63% 69.67% 0.00% 6.54% 0.00% 12.76%
Net Income Q/Q Growth
67.25% 49.03% -75.55% -45.08% 178.69% -76.12% 17.34% 0.00% -134.54% 0.00% 12.63%
EPS Q/Q Growth
67.78% 51.72% -85.71% -46.15% 100.00% 0.00% -78.38% 0.00% -83.33% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-38.38% 136.12% 10.24% -10.05% -16.15% 17.68% 12.67% 0.00% 0.00% 15.56% 8.74%
Free Cash Flow Firm Q/Q Growth
-58.43% 115.73% 1,047.37% -69.76% 127.71% -45.35% -357.55% 0.00% 496.84% 0.00% -68.78%
Invested Capital Q/Q Growth
166.49% -152.38% -267.55% -24.22% 76.84% -155.56% 100.00% 0.00% 45.93% 0.00% -17.03%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
82.08% 82.24% 81.63% 81.67% 82.97% 81.03% 81.95% 81.63% 81.24% 80.54% 79.84%
EBITDA Margin
-6.61% -0.71% -4.80% -6.98% 13.85% 5.49% 6.38% 11.43% 1.34% 3.75% 6.88%
Operating Margin
-19.89% -13.99% -18.57% -21.25% -8.55% -6.47% -2.15% -5.99% -8.08% -5.24% -4.36%
EBIT Margin
-11.23% -5.11% -8.96% -12.17% 9.96% 2.21% 2.84% 9.27% -2.87% -0.71% -0.50%
Profit (Net Income) Margin
-11.42% -5.36% -9.14% -12.69% 9.85% 2.21% 2.49% 9.25% -3.24% -0.75% -0.62%
Tax Burden Percent
101.77% 104.88% 101.91% 104.30% 98.85% 99.99% 87.54% 99.87% 112.56% 105.30% 125.27%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 1.15% 0.01% 12.46% 0.13% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-141.65% 0.00% 0.00% 0.00% -272.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-141.82% 0.00% 0.00% 0.00% -274.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
138.54% 0.00% 0.00% 0.00% 271.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-3.11% -5.50% -4.22% -1.95% -1.12% -0.70% 0.00% 0.00% 0.00% 0.31% -0.64%
Cash Return on Invested Capital (CROIC)
-414.45% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-1.16% -0.57% -1.11% -1.55% 1.34% 0.30% 0.00% 0.00% 0.00% -0.11% -0.08%
Return on Assets (ROA)
-1.18% -0.60% -1.13% -1.61% 1.32% 0.30% 0.00% 0.00% 0.00% -0.11% -0.10%
Return on Common Equity (ROCE)
-3.11% -5.50% -4.22% -1.95% -1.12% -0.70% 0.00% 0.00% 0.00% 0.31% -0.64%
Return on Equity Simple (ROE_SIMPLE)
-7.13% 0.00% -4.23% -1.99% -1.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-38 -29 -40 -47 -27 -22 -6.74 -22 -20 -15 -13
NOPAT Margin
-13.92% -9.79% -13.00% -14.87% -8.45% -6.47% -1.88% -5.98% -5.66% -3.66% -3.05%
Net Nonoperating Expense Percent (NNEP)
0.17% 0.32% 0.28% 0.16% 1.46% 0.70% 0.00% 1.28% 0.21% 0.52% 0.23%
Return On Investment Capital (ROIC_SIMPLE)
- - - -0.82% - - - -0.39% -0.36% -0.25% -0.22%
Cost of Revenue to Revenue
17.92% 17.76% 18.37% 18.33% 17.03% 18.97% 18.05% 18.37% 18.76% 19.46% 20.16%
SG&A Expenses to Revenue
26.31% 13.93% 24.02% 22.00% 25.25% 7.33% 18.63% 19.62% 20.62% 19.44% 19.17%
R&D to Revenue
28.90% 27.65% 29.20% 27.16% 25.26% 23.16% 21.95% 23.39% 24.16% 20.29% 19.97%
Operating Expenses to Revenue
101.97% 96.23% 100.20% 102.92% 91.52% 87.49% 84.10% 87.62% 89.32% 85.78% 84.20%
Earnings before Interest and Taxes (EBIT)
-31 -15 -27 -39 32 7.60 10 34 -10 -2.81 -2.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 -2.09 -15 -22 45 19 23 41 4.80 15 29
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.10 0.00 2.88 2.20 1.78 1.35 0.00 2.30 1.21 1.39 1.43
Price to Tangible Book Value (P/TBV)
6.51 0.00 8.56 7.06 5.31 3.84 0.00 7.56 3.79 4.21 4.49
Price to Revenue (P/Rev)
8.97 0.00 10.21 6.99 5.81 4.33 4.19 0.00 0.00 3.59 3.52
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 712.95 0.00 0.00 451.43 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.14% 0.00% 0.00% 0.22% 0.00%
Enterprise Value to Invested Capital (EV/IC)
27.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
4.88 0.00 6.38 3.49 2.47 0.94 0.00 0.00 0.00 0.64 0.66
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 435.92 43.06 0.00 0.00 0.00 12.06 16.80
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55.08 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
48.49 0.00 32.38 17.54 10.95 4.33 0.00 14.39 1.62 2.67 2.65
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 35.43 130.02 23.13 37.83 0.00 0.00 0.00 2.01 8.96
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.45 0.45 0.23 0.47 0.28 0.22 0.00 0.45 0.44 0.48 0.48
Long-Term Debt to Equity
0.45 0.42 0.23 0.43 0.28 0.22 0.00 0.44 0.43 0.47 0.48
Financial Leverage
-0.98 -1.01 -1.03 -1.08 -0.99 -1.04 0.00 -1.11 -1.04 -1.14 -1.14
Leverage Ratio
2.27 2.32 2.27 2.44 2.27 2.29 0.00 2.52 2.37 2.61 2.60
Compound Leverage Factor
2.27 2.32 2.27 2.44 2.27 2.29 0.00 2.52 2.37 2.61 2.60
Debt to Total Capital
30.93% 31.05% 18.56% 31.81% 22.02% 18.11% 0.00% 31.01% 30.68% 32.46% 32.51%
Short-Term Debt to Total Capital
0.00% 2.28% 0.00% 2.33% 0.00% 0.00% 0.00% 0.60% 0.60% 0.58% 0.00%
Long-Term Debt to Total Capital
30.93% 28.77% 18.56% 29.48% 22.02% 18.11% 0.00% 30.40% 30.08% 31.87% 32.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
69.07% 68.95% 81.44% 68.19% 77.98% 81.89% 0.00% 69.00% 69.32% 67.54% 67.49%
Debt to EBITDA
-8.59 -11.68 -8.18 -101.33 162.73 32.62 0.00 0.00 0.00 23.45 30.13
Net Debt to EBITDA
18.38 26.52 38.85 239.92 -589.76 -156.26 0.00 0.00 0.00 -55.61 -72.96
Long-Term Debt to EBITDA
-8.59 -10.83 -8.18 -93.90 162.73 32.62 0.00 0.00 0.00 23.03 30.13
Debt to NOPAT
-7.78 -8.89 -4.94 -15.40 -8.47 -7.50 0.00 0.00 0.00 -29.11 -29.11
Net Debt to NOPAT
16.63 20.17 23.45 36.46 30.70 35.91 0.00 0.00 0.00 69.01 70.49
Long-Term Debt to NOPAT
-7.78 -8.23 -4.94 -14.27 -8.47 -7.50 0.00 0.00 0.00 -28.58 -29.11
Altman Z-Score
1.35 0.00 1.58 1.18 1.15 0.93 0.00 0.00 0.00 0.79 0.78
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.92 1.78 1.53 1.69 1.63 1.55 0.00 1.66 1.69 1.67 1.65
Quick Ratio
0.81 0.72 0.37 0.63 0.48 0.40 0.00 0.54 0.55 0.54 0.52
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-194 30 350 106 241 132 -339 22 131 527 164
Operating Cash Flow to CapEx
338.31% 1,075.27% 1,258.45% 1,557.18% 1,735.75% 1,422.47% 1,255.41% 0.00% 1,105.15% 663.71% 742.51%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.10 0.11 0.12 0.13 0.13 0.14 0.00 0.00 0.00 0.15 0.16
Accounts Receivable Turnover
31.60 40.49 37.17 43.01 38.85 45.85 0.00 0.00 0.00 46.71 44.30
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
14.73 15.28 14.91 15.97 15.08 15.21 0.00 0.00 0.00 11.63 14.01
Accounts Payable Turnover
19.90 21.01 18.06 19.49 27.80 29.39 0.00 0.00 0.00 40.64 55.98
Days Sales Outstanding (DSO)
11.55 9.01 9.82 8.49 9.39 7.96 0.00 0.00 0.00 7.81 8.24
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
18.34 17.37 20.21 18.73 13.13 12.42 0.00 0.00 0.00 8.98 6.52
Cash Conversion Cycle (CCC)
-6.79 -8.36 -10.39 -10.24 -3.73 -4.46 0.00 0.00 0.00 -1.17 1.72
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
173 -90 -332 -413 -96 -244 0.00 -456 -247 -541 -633
Invested Capital Turnover
10.17 -17.45 -8.24 -3.71 32.27 -7.71 0.00 0.00 0.00 -5.54 -2.85
Increase / (Decrease) in Invested Capital
156 -59 -389 -153 -268 -154 332 -44 -151 -541 -177
Enterprise Value (EV)
4,700 0.00 7,229 4,346 3,071 1,207 0.00 4,502 561 959 1,022
Market Capitalization
8,632 0.00 11,574 8,710 7,225 5,585 5,629 8,767 4,678 5,383 5,463
Book Value per Share
$38.58 $38.56 $37.65 $37.02 $38.61 $38.95 $0.00 $36.81 $37.97 $38.20 $38.01
Tangible Book Value per Share
$12.47 $12.53 $12.68 $11.56 $12.95 $13.72 $0.00 $11.21 $12.12 $12.58 $12.16
Total Capital
5,942 5,926 4,928 5,795 5,205 5,048 0.00 5,521 5,584 5,748 5,640
Total Debt
1,838 1,840 915 1,843 1,146 914 0.00 1,712 1,713 1,866 1,834
Total Long-Term Debt
1,838 1,705 915 1,708 1,146 914 0.00 1,678 1,680 1,832 1,834
Net Debt
-3,932 -4,176 -4,345 -4,364 -4,154 -4,378 0.00 -4,266 -4,117 -4,424 -4,440
Capital Expenditures (CapEx)
10 7.47 7.04 5.12 3.85 5.53 7.06 0.00 9.01 15 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2,700 -2,961 -3,112 -3,235 -2,899 -3,041 0.00 -3,226 -3,011 -3,305 -3,379
Debt-free Net Working Capital (DFNWC)
3,070 3,055 2,148 2,973 2,402 2,252 0.00 2,751 2,820 2,985 2,895
Net Working Capital (NWC)
3,070 2,920 2,148 2,838 2,402 2,252 0.00 2,718 2,786 2,952 2,895
Net Nonoperating Expense (NNE)
-6.81 -13 -12 -6.95 -59 -30 -16 -55 -8.67 -12 -10
Net Nonoperating Obligations (NNO)
-3,932 -4,176 -4,345 -4,364 -4,154 -4,378 0.00 -4,266 -4,117 -4,424 -4,440
Total Depreciation and Amortization (D&A)
13 13 13 17 13 11 13 7.86 15 18 31
Debt-free, Cash-free Net Working Capital to Revenue
-280.48% -279.78% -274.52% -259.72% -233.29% -235.67% 0.00% 0.00% 0.00% -220.33% -217.69%
Debt-free Net Working Capital to Revenue
318.87% 288.60% 189.54% 238.69% 193.32% 174.53% 0.00% 0.00% 0.00% 199.02% 186.55%
Net Working Capital to Revenue
318.87% 275.84% 189.54% 227.85% 193.32% 174.53% 0.00% 0.00% 0.00% 196.79% 186.55%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.29) ($0.14) ($0.26) ($0.38) $0.30 $0.07 $0.00 $0.33 ($0.11) ($0.03) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding
106.60M 105.98M 106.82M 105.91M 105.44M 106.10M 0.00 103.10M 102.22M 101.92M 100.53M
Adjusted Diluted Earnings per Share
($0.29) ($0.14) ($0.26) ($0.38) $0.00 $0.37 $0.00 ($0.06) ($0.11) ($0.03) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding
106.60M 105.98M 106.82M 105.91M 111.18M 106.10M 0.00 104.48M 102.22M 101.92M 100.53M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
106.27M 106.61M 103.50M 105.13M 106.14M 106.69M 0.00 101.95M 103.03M 100.16M 98.96M
Normalized Net Operating Profit after Tax (NOPAT)
-38 -29 -40 -30 -25 -22 -6.74 -22 -20 -8.29 -12
Normalized NOPAT Margin
-13.92% -9.79% -13.00% -9.36% -7.81% -6.47% -1.88% -5.98% -5.66% -2.10% -2.98%
Pre Tax Income Margin
-11.23% -5.11% -8.96% -12.17% 9.96% 2.21% 2.84% 9.27% -2.87% -0.71% -0.50%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-8.20% -39.16% -58.65% -381.46% -526.36% -733.78% 2,684.00% 0.00% 0.00% 2,625.95% -1,015.23%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for BILL Holdings, Inc. (NYSE: BILL) based on the last four years of quarterly cash flow, income statement, and balance sheet data. The bullets below are organized with positive items first, then neutral items, and finally negative items.

  • Revenue growth across the period: Operating revenue has trended higher, rising from roughly $318.5M in Q2 2024 to about $414.7M in Q2 2026 (approximately a 30% increase). This indicates ongoing top-line growth despite fluctuations in quarterly profitability.
  • Consistent positive cash flow from operations: BILL has posted solid cash generation from operations in the latest periods, with net cash from continuing operating activities around $105.3M in Q2 2026 and about $97.0M in Q3 2025, supporting liquidity even when net income is negative in some quarters.
  • Healthy gross margins maintained: Gross margins have remained strong, typically around the 80% level (e.g., Q2 2026 gross margin ≈ 80%), suggesting pricing power or favorable cost structure for core offerings.
  • Stable liquidity in the near term: Total current assets (~$7.3B) exceed total current liabilities (~$4.4B) in the latest quarter, supporting a healthy current ratio and near-term liquidity.
  • Moderate leverage profile next to equity base: Long-term debt (~$1.83B) versus total equity (~$3.81B) in Q2 2026 implies a debt-to-equity ratio under 0.5, indicating a manageable leverage level relative to equity.
  • Very large restricted cash balances: Restricted cash has remained substantial across periods (e.g., about $3.6B–$4.0B), which can limit immediate liquidity despite overall cash holdings.
  • Significant goodwill and intangible assets: Goodwill remains around $2.4B with notable intangible assets, reflecting prior acquisitions and potential impairment risk if operating results falter.
  • Net income frequently negative: Quarterly net income has been negative in multiple periods (for example, a Q2 2026 net loss of about $2.6M; other quarters show larger losses), signaling ongoing profitability challenges.
  • Negative operating income in several quarters: Operating income has been negative in several periods (e.g., Q2 2026 about -$18.1M; Q3 2025 about -$28.9M), indicating sustained cost pressures relative to revenue.
  • Significant cash outflows from investing and financing activities in some quarters: Investing cash flows have been broadly negative in several periods (e.g., Q3 2025 around -$644.1M; Q2 2026 around -$136.6M), and financing activities have shown substantial net outflows in multiple quarters, contributing to fluctuations in cash balances.
05/06/26 05:46 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About BILL's Financials

When does BILL's financial year end?

According to the most recent income statement we have on file, BILL's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

How has BILL's net income changed over the last 7 years?

BILL's net income appears to be on an upward trend, with a most recent value of $23.80 million in 2025, falling from -$7.20 million in 2018. The previous period was -$28.88 million in 2024. Check out BILL's forecast to explore projected trends and price targets.

What is BILL's operating income?
BILL's total operating income in 2025 was -$80.60 million, based on the following breakdown:
  • Total Gross Profit: $1.19 billion
  • Total Operating Expenses: $1.27 billion
How has BILL's revenue changed over the last 7 years?

Over the last 7 years, BILL's total revenue changed from $64.87 million in 2018 to $1.46 billion in 2025, a change of 2,154.8%.

How much debt does BILL have?

BILL's total liabilities were at $6.15 billion at the end of 2025, a 21.9% increase from 2024, and a 354.7% increase since 2019.

How much cash does BILL have?

In the past 6 years, BILL's cash and equivalents has ranged from $90.31 million in 2019 to $1.62 billion in 2023, and is currently $1.04 billion as of their latest financial filing in 2025.

How has BILL's book value per share changed over the last 7 years?

Over the last 7 years, BILL's book value per share changed from 0.00 in 2018 to 37.99 in 2025, a change of 3,799.0%.



Financial statements for NYSE:BILL last updated on 2/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners